Skip to main content
. 2021 Sep 24;12:759267. doi: 10.3389/fphar.2021.759267

FIGURE 9.

FIGURE 9

LINC01001 overexpression increases crizotinib-resistance of NSCLC via MYC in vivo . (A) Tumor size. (B) Statistical analysis of tumor volume. (C) Statistical analysis of tumor weight. (D) H&E staining and IHC staining of Ki67 in tumor tissues. *p < 0.05, ***p < 0.001 vs NC group, #p < 0.05, ##p < 0.01, ###p < 0.001 vs LINC01001+sh-NC group. Error bars represent SD. Data represent three independent experiments.